SH2域
原癌基因酪氨酸蛋白激酶Src
酪氨酸激酶
药物发现
SH3域
机制(生物学)
蛋白激酶结构域
信号转导
计算生物学
磷酸化
生物
细胞生物学
化学
癌症研究
生物化学
基因
物理
量子力学
突变体
作者
Robert J. Broadbridge,Ram Prakash Sharma
标识
DOI:10.2174/1389450003349074
摘要
Src homology 2 (SH2) domains are found in many intercellular signal-transduction proteins which bind phosphotyrosine containing polypeptide sequences with high affinity and specificity and are considered potential targets for drug discovery. The protein p56 lck is a member of the family of Src tyrosine kinase. The SH2 domain is thought to be responsible for the recruitment and regulation of p56 lck kinase activity. There have been enormous efforts in the development of SH2 domain inhibitors for diseases such as cancer, osteoporosis and other diseases. This review focuses on current understanding of SH2 domain structure, mechanism and drug discovery with an emphasis on p56 lck SH2 domain. A potential impact of the accumulated crystallographic effort on the development of methods for structure-based drug design is briefly addressed. Keywords: Src homology, SH2 Domains, protein tyrosin, Kinase p56, T cell activation, stimulated signalling
科研通智能强力驱动
Strongly Powered by AbleSci AI